The stock of newly state-owned firm listed at its issue price of Rs. 19 per share. In the morning session, the company traded at a market capitalisation of Rs. 3,982.39 crore on Thursday.  

Overall volumes in futures & options currently stand at 1.73 crore contracts with a turnover of Rs. 11,59,692.41 crore.

Pharma major Wockhardt has received approval from the United States Food & Drug Administration (USFDA) for an ANDA for 50 mg injection of Decibatine, which is used in the treatment of some forms of cancer. Decibatine injection is a generic version of Dacogen, marketed in the USA and other countries by Otsuka.

Overall volumes in futures & options currently stand at 1.73 crore contracts with a turnover of Rs. 11,59,692.41 crore.

Traders will closely monitor two key levels, namely, 11,540 and 11,710, as we have seen the index has been trading in this range since last four-five trading session. Any breakout on either side of this range would lead to an explosive move. Stocks in news: JSW Steel, Wockhardt, Info Edge, Kansai Nerolac Paints, Sobha, Tanla Solutions, Wipro, TCS.

Markets may begin the day with modest gains as indicated by the SGX Nifty and also, slightly encouraging cues from the Wall Street overnight. At the time of writing, SGX Nifty was trading higher by 22 points at 11,673 level. The much awaited event, the general election will garner the attention of the investors going ahead as the first phase of election in the world’s largest democracy begins today.

Most sugar stocks were trading with losses in Wednesday's trading session.

Investors will be pleased to learn that the dismal scenario in the real estate sector is undergoing substantial transformation and an end to the gloomy sales performance appears to be in sight.

Pharma major Lupin announced the launch of Fluoxetine Tablets USP, 60mg, having received approval from the United States Food and Drug Administration (FDA) earlier.

The financial year just ended saw a sharp downfall in the investment in equity mutual fund schemes. Read to find the reasons.